Acebutolol Hydrochloride
Product Images NDC 54868-4216

5 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 54868-4216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 400 mg Package Label (4216)

Image Of 400 mg Package Label (4216)
The packaging label for Acebutolol Hydrochloride 400 mg capsules from Physicians Total Care, Inc. displays the active ingredient name, strength as 400 mg, and the count of 30 capsules per container. It includes cautionary statements about federal law and storage instructions, along with barcode and lot number details.*
FDA Label Image

Image Of 200 mg Package Label (5520)

Image Of 200 mg Package Label (5520)
Acebutolol Hydrochloride 200 mg capsules packaging label from Physicians Total Care, Inc. The label shows the product name ACEBUTOLOL HCL, strength of 200 mg, and quantity of 30 capsules. It includes cautionary text about federal law restricting dispensing without prescription, and dosage and storage instructions. The label also displays the NDC number 54868-5520-30 and a barcode.*
FDA Label Image

F1931f84-figure-01 (F1931f84 Figure 01)

F1931f84-figure-01 (F1931f84 Figure 01)
Chemical structure of Acebutolol Hydrochloride showing its molecular composition and arrangement, including functional groups such as hydroxyl, amide, and aromatic rings.*
FDA Label Image

F1931f84-figure-02 (F1931f84 Figure 02)

F1931f84-figure-02 (F1931f84 Figure 02)
A data table titled 'Total Volunteered and Elicited (U.S. Studies)' presenting percentages of reported adverse reactions by body system for four groups: Acebutolol (N=1002), Propranolol (N=424), Hydrochlorothiazide (N=178), and Placebo (N=314). Adverse reactions include categories such as cardiovascular, central nervous system, dermatologic, gastrointestinal, genitourinary, musculoskeletal, respiratory, and special senses with specific symptoms and their respective occurrence percentages.*
FDA Label Image

F1931f84-figure-03 (F1931f84 Figure 03)

F1931f84-figure-03 (F1931f84 Figure 03)
A data table showing the percentage distribution of adverse effects of Acebutolol Hydrochloride across different body systems at three dosage levels: 400 mg/day, 800 mg/day, and 1200 mg/day. Body systems listed include cardiovascular, gastrointestinal, musculoskeletal, central nervous system, respiratory, skin, special senses, and genitourinary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.